Soroka University Medical Center
Clinical trials sponsored by Soroka University Medical Center, explained in plain language.
-
New once-daily pill shows promise against rare liver virus
Disease control CompletedThis study tested a once-daily combination of two drugs (lonafarnib and ritonavir) in 10 adults with chronic hepatitis D, a serious liver infection. The goal was to see if the treatment is safe and can lower virus levels over 48 weeks, with a 24-week follow-up. Participants had s…
Phase: PHASE3 • Sponsor: Soroka University Medical Center • Aim: Disease control
Last updated May 26, 2026 12:01 UTC
-
Experimental COVID-19 drug shows promise in small pilot trial
Disease control CompletedThis study tested whether adding pegylated interferon lambda to standard care helps hospitalized COVID-19 patients recover faster. Nine adults with mild to moderate symptoms were randomly assigned to receive either the drug plus standard care or standard care alone. The main goal…
Phase: PHASE2 • Sponsor: Soroka University Medical Center • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Minutes vs. days: new rapid test could speed up thyroid cancer detection
Diagnosis CompletedThis study tested a new rapid test (POC-Tg) that measures thyroglobulin levels in fluid from a lymph node biopsy to quickly detect if thyroid cancer has spread. Currently, patients wait days to weeks for results. The new test aims to give results in minutes, helping doctors make …
Sponsor: Soroka University Medical Center • Aim: Diagnosis
Last updated May 14, 2026 12:02 UTC
-
Can elliptical training improve walking in MS patients?
Symptom relief CompletedThis study looked at whether using an elliptical trainer or a treadmill is better for improving walking, balance, and stability in people with multiple sclerosis (MS). Thirty adults with moderate MS completed the exercise program. The goal was to see which machine helps more with…
Phase: NA • Sponsor: Soroka University Medical Center • Aim: Symptom relief
Last updated May 26, 2026 11:09 UTC